Vicarious Surgical (NYSE:RBOT) Director Donald Tang Sells 2,753 Shares

Vicarious Surgical Inc. (NYSE:RBOT) Director Donald Tang sold 2,753 shares of the company’s stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $6.70, for a total value of $18,445.10. Following the sale, the director owned 40,425 shares of the company’s stock, valued at $270,847.50. This trade represents a 6.38% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Vicarious Surgical Price Performance

Vicarious Surgical stock opened at $6.58 on Thursday. Vicarious Surgical Inc. has a 12 month low of $5.00 and a 12 month high of $19.00. The business has a 50 day simple moving average of $8.50 and a 200-day simple moving average of $8.43. The stock has a market capitalization of $39.04 million, a PE ratio of -0.65 and a beta of 1.41.

Vicarious Surgical (NYSE:RBOT) last released its quarterly earnings results on Tuesday, August 12th. The company reported ($2.23) EPS for the quarter, topping the consensus estimate of ($2.61) by $0.38. As a group, equities research analysts anticipate that Vicarious Surgical Inc. will post -10.89 EPS for the current year.

Analysts Set New Price Targets

Separately, Piper Sandler cut their price target on Vicarious Surgical from $8.50 to $7.00 and set a “neutral” rating for the company in a research note on Wednesday, August 13th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $7.00.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of RBOT. Geode Capital Management LLC raised its position in Vicarious Surgical by 8.2% in the fourth quarter. Geode Capital Management LLC now owns 30,799 shares of the company’s stock worth $405,000 after acquiring an additional 2,336 shares in the last quarter. Renaissance Technologies LLC grew its holdings in Vicarious Surgical by 11.6% in the fourth quarter. Renaissance Technologies LLC now owns 11,534 shares of the company’s stock valued at $152,000 after purchasing an additional 1,200 shares during the last quarter. DDD Partners LLC grew its holdings in Vicarious Surgical by 15.3% in the first quarter. DDD Partners LLC now owns 213,824 shares of the company’s stock valued at $1,403,000 after purchasing an additional 28,357 shares during the last quarter. Finally, DNB Asset Management AS grew its holdings in Vicarious Surgical by 12.1% in the second quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock valued at $219,000 after purchasing an additional 3,154 shares during the last quarter. Hedge funds and other institutional investors own 47.27% of the company’s stock.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.